Josephine Hendrikson
Overview
Explore the profile of Josephine Hendrikson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
48
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chong Y, Thiagarajan S, Tan Q, Lim H, Tan J, Hendrikson J, et al.
Sci Rep
. 2024 Jul;
14(1):17522.
PMID: 39080370
Peritoneal metastasis (PM), the regional progression of intra-abdominal malignancies, is a common sequelae of colorectal cancer (CRC). Immunotherapy is slated to be effective in generating long-lasting anti-tumour response as it...
2.
Tan Q, Shannon N, Lim W, Teo J, Yap D, Lek S, et al.
Front Oncol
. 2024 Jun;
14:1272432.
PMID: 38939336
Introduction: Field cancerization is suggested to arise from imbalanced differentiation in individual basal progenitor cells leading to clonal expansion of mutant cells that eventually replace the epithelium, although without evidence....
3.
Liu Y, Ng W, Zhu H, Tan Q, Hendrikson J, Tan J, et al.
STAR Protoc
. 2022 Jul;
3(3):101548.
PMID: 35842864
Clinically relevant animal models are crucial for effective development of therapeutics for peritoneal carcinomatosis (PC). This protocol describes the generation of patient-derived ascites-dependent xenograft (PDADX) models from the cellular component...
4.
Hendrikson J, Liu Y, Ng W, Lee J, Lim A, Loh J, et al.
Cell Rep Med
. 2022 Mar;
3(2):100526.
PMID: 35243423
Peritoneal carcinomatosis (PC) present a ubiquitous clinical conundrum in all intra-abdominal malignancies. Via functional and transcriptomic experiments of ascites-treated PC cells, we identify STAT3 as a key signaling pathway. Integrative...
5.
Shannon N, Tan L, Tan Q, Tan J, Hendrikson J, Ng W, et al.
Sci Rep
. 2021 Aug;
11(1):16829.
PMID: 34413360
Ovarian cancer is associated with poor prognosis. Platinum resistance contributes significantly to the high rate of tumour recurrence. We aimed to identify a set of molecular markers for predicting platinum...
6.
Shannon N, Tan Q, Tan J, Hendrikson J, Ng W, Ng G, et al.
Cancers (Basel)
. 2021 Jul;
13(12).
PMID: 34207401
Up to 10% of well-differentiated liposarcoma (WDLS) progress to dedifferentiated liposarcoma (DDLS). We aimed to identify gene expression changes associated with dedifferentiation and whether these were informative of tumour biology...
7.
Tan J, Thiagarajan S, Zhou S, Tan Q, Hendrikson J, Ng W, et al.
Ann Surg Oncol
. 2021 Mar;
28(11):6636-6637.
PMID: 33733373
No abstract available.
8.
Thiagarajan S, Tan J, Zhou S, Tan Q, Hendrikson J, Ng W, et al.
Ann Surg Oncol
. 2021 Mar;
28(11):6625-6635.
PMID: 33655363
Background: The prognostic significance of inflammatory markers in solid cancers is well-established, albeit with considerable heterogeneity. This study sought to investigate the postoperative inflammatory marker trend in peritoneal carcinomatosis (PC),...
9.
Lek S, Li K, Tan Q, Shannon N, Ng W, Hendrikson J, et al.
Oral Oncol
. 2020 Oct;
111:105035.
PMID: 33091845
Objectives: We have previously identified and validated a panel of molecular prognostic markers (ATP13A3, SSR3, and ANO1) for Head and Neck Squamous Cell Carcinoma (HNSCC). The aim of this study...
10.
Ragavan S, Lim H, Tan J, Hendrikson J, Chan J, Farid M, et al.
Sarcoma
. 2020 Apr;
2020:4890803.
PMID: 32300278
Angiosarcomas of the breast (ASB) are rare, making up to less than 8% of all angiosarcomas. The surgical management for this disease continues to vary throughout centres worldwide due to...